Asymmetry in Therapeutics

Unmet medical needs persist across key therapeutic areas, yet pipeline assets trade at significant value dislocations. Identifying these asymmetries presents a unique opportunity to capture mispriced innovation.

A deeper write-up on this theme is coming soon.